Abstract
We have quantified the level of β4-galactosyltransferase protein in human B lymphocytes using an ELISA-based assay. Between 1-10ng of β4-galactosyltransferase was detected per mg total cellular protein, indicating that this enzyme constitutes <0.001% of B lymphocyte cellular protein. Akin to previous studies, individuals with rheumatoid arthritis exhibited reduced lymphocytic galactosyltransferase enzyme activity compared with normal controls when using ovalbumin as the acceptor substrate. The levels of enzyme protein present in B lymphocytes from patients with rheumatoid arthritis was, however, not reduced suggesting that the B lymphocyte galactosyltransferase catalytic activity may be regulated post-translationally.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Varki A (1993) Glycobiology 3: 97–130.
Wright A, Morrison SL (1998) J Immunol 160: 3393–402.
Parekh R, Isenberg D, Rook G, Roitt I, Dwek R, Rademacher T (1989) J Autoimmun 2: 101–14.
Bond A, Alavi A, Axford JS, Bourke BE, Bruckner FE, Kerr MA, Maxwell JD, Tweed KJ, Weldon MJ, Youinou P, Hay FC (1997) J Autoimmun 10: 77–85.
Isenberg DA, Rademacher TW (1996) Abnormalities of IgG Glycosylation and Immunological Disorders Chichester: John Wiley and Sons.
Rademacher TW, Williams P, Dwek RA (1994) Proc Natl Acad Sci USA 91: 6123–27.
van Zeben D, Rook GAW, Hazes JMW, Zwinderman AH, Zhang Y, Ghelani S, Rademacher TW, Breedveld FC (1994) Brit J Rheumatol 33: 36–43.
Axford JS, Mackenzie L, Lydyard PM, Hay FC, Isenberg DA, Roitt IM (1987) Lancet 2: 1486–88.
Furukawa K, Matsuta K, Takeuchi F, Kosuge E, Miyamoto T, Kobata A (1990) Int Immunol 2: 105–12.
Wilson IB, Platt FM, Isenberg DA, Rademacher TW (1993) J Rheumatol 20: 1282–87.
Almeida R, Amado M, David L, Levery SB, Holmes EH, Merkx G, van Kessel AG, Rygaard E, Hassan H, Bennett E, Clausen H (1997) J Biol Chem 272: 31979–91.
Sato T, Furukawa K, Bakker H, Van den Eijnden DH, Van Die I (1998) Proc Natl Acad Sci USA 95: 472–77.
Lo N-W, Shaper JH, Pevsner J, Shaper NL (1998) Glycobiology 8: 517–26.
Keusch J, Lydyard PM, Delves PJ (1998) Glycobiology 8: 1215–20.
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. (1988) Arthritis Rheum 31: 315–24.
Jeddi PA, Bodman-Smith K, Lund T, Lydyard PM, Mengle-Gaw L, Isenberg DA, Youinou P, Delves PJ (1996) Immunology 87: 654–59.
Keusch J, Lydyard PM, Isenberg DA, Delves PJ (1995) Glycobiology 5: 365–70.
Keusch J, Panayotou G, Malissard M, Berger EG, Appert HE, Lydyard PM, Delves PJ (1998). Carb Res 313: 37–48.
Gerber AC, Kozdrowski I, Wyss SR, Berger EG (1979) Eur J Biochem 93: 453–60.
Watzele G, Bachofner R, Berger EG (1991) Eur J Cell Biol 56: 451–58.
Bradford MM (1976) Anal Biochem 72:248–54.
Sumar N, Bodman KB, Rademacher TW, Dwek RA, Williams P, Parekh RB, Edge J, Rook GA, Isenberg DA, Hay FC, Roitt IM (1990) J Immunol Methods 131: 127–36.
Strous GJ, van Kerkhof P, Fallon RJ, Schwartz AL (1987) Eur J Biochem 169: 307–11.
Berger EG, Grimm K, Bachi T, Bosshart H, Kleene R, Watzele M (1993) J Cell Biochem 52: 275–88.
Winfield J, Jarjour W (1994) Adv Exp Med Biol 347: 99–113.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Keusch, J., Lydyard, P.M., Berger, E.G. et al. B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis. Glycoconj J 15, 1093–1097 (1998). https://doi.org/10.1023/A:1006957711557
Issue Date:
DOI: https://doi.org/10.1023/A:1006957711557